Martin A. Cheever

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

Nature Communications(2021)10.1038/s41467-021-26974-6

N/A

4.0DataRank · unranked

227 citations

Magdalena Matusiak, Belén Rivero‐Gutiérrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang +13 more

Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy

Science Translational Medicine(2022)10.1126/scitranslmed.abl3836

N/A

2.0DataRank · unranked

103 citations

Scott V. Adams, Rémi Fromentin, Michael Roche, Steven P. Fling, Priscila Gonçalves +19 more

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010291

N/A

0.401DataRank · unranked

10 citations

Angela Shaulov Kask, Leonard D’Amico, Manoj Menon, Kathryn Lurain, Robert Yarchoan +13 more

New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy

Patterns(2021)10.1016/j.patter.2021.100372

N/A

0DataRank · unranked

43 citations

Greg Finak, Leonard D’Amico, Nina Bhardwaj, Candice D. Church, Chihiro Morishima +7 more

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

Research Square(2021)10.21203/rs.3.rs-122285/v1

N/A

0DataRank · unranked

6 citations

Darci J. Phillips, Magdalena Matusiak, Belén Gutiérrez‐Gutiérrez, Salil S. Bhate, Graham L. Barlow +13 more

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1728

N/A

0DataRank · unranked

7 citations

Gurkamal Chatta, Rohit K. Jain, Helen Moon, Scott E. Delacroix, Alana Fang +10 more

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002903

N/A

0DataRank · unranked

67 citations

Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard J. Appleman, Paul Monk +18 more

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1047

N/A

0DataRank · unranked

183 citations

Courtney B. Betts, Rosemarie Mick, Shamilene Sivagnanam, David L. Bajor, Daniel A. Laheru +24 more

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002097

N/A

0DataRank · unranked

69 citations

Ramya Ramaswami, Ralph Mangusan, Anaida Widell, Irene Ekwede, Jomy George +8 more

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

medRxiv(2020)10.1101/2020.12.06.20244913

N/A

0DataRank · unranked

19 citations

Magdalena Matusiak, Belén Rivero‐Gutiérrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang +13 more